Evidence Synthesis
Panacea Pharmaceuticals (PANCM) has experienced a positive shift in its financial performance, with several key metrics indicating an improvement in the company's overall health.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 06:05
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Panacea Pharmaceuticals (PANCM) has experienced a positive shift in its financial performance, with several key metrics indicating an improvement in the company's overall health.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 1.73 % | -40.01 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -40.01 % | -45.05 | ▲ |
| REVENUE_GROWTH_YOY | 9,495.5 % | — | - |
| PRICE_CHANGE_PERCENT | 4.991 % | — | - |
| DAILY_VOLUME | 552 shares | 338 | ▲ |
| CLOSE_PRICE | 115.7 INR | 110.2 | ▲ |